Showing 861 - 880 of 978 results
ANSTO offers a broad range of programs and services to various industries and customers. Many of these services, including the Australian Nuclear Medicine Traceability program, are supported by online customer portals.
Over the last decades, neutron, photon, and ion beams have been established as an innovative and attractive investigative approach to characterise cultural-heritage materials.
Five exceptional female science communicators are part of a larger team who use skills in education and engagement to promote an interest in science amongst the public and students.
Sri Lankan students took part in an innovative hackathon to develop novel solutions to a wastewater runoff problem from reverse osmosis water treatment plants.
The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.
Monash University researchers have used advanced techniques at ANSTO to investigate the production of new, elongated polymer nanocapsules with a high payload of drug nanocrystals to potentially increase drug targetability, and also decrease dosage frequency and side effects.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.
Commitment to undertake health research.
Resources and a list of user publications associated with Infrared microspectroscopy.
Two early career nuclear scientists who received international scholarships have spent time in the Nuclear Fuel Cycle group at ANSTO are making progress on their work to improve nuclear fuel.
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program
Role at ANSTO